Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan Pang

Showing results (391-400 of 410) with videos related to

Pageof 41
Sort By:
Oncotarget|February 10, 2017
Pravastatin activates activator protein 2 alpha to augment the angiotensin II-induced abdominal aortic aneurysmsHui Ma, Wen-Jing Liang, Mei-Rong Shan, et al.
Gastrointestinal Endoscopy|December 13, 2021
Colorectal cancer patients advocating screening to their siblings: a randomized behavioral interventionLina Choe, Jerrald Lau, Si-Ying Fong, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 7, 2021
Clinical Implication of E2F Transcription Factor 1 in Hepatocellular Carcinoma TissuesWang-Yang Ye, Hui-Ping Lu, Jian-Di Li, et al.
Discover Oncology|July 4, 2025
Molecular mechanism and biological pathway of high-expressed RAD51 in regulating cell adhesion and potentially affecting oral squamous cell carcinomaYu-Xing Tang, Yu-Yan Pang, Yan Cui, et al.
Acta Pharmacologica Sinica|May 30, 2017
Xyloketal B alleviates cerebral infarction and neurologic deficits in a mouse stroke model by suppressing the ROS/TLR4/NF-κB inflammatory signaling pathwayNi Pan, Liu-Yi Lu, Mei Li, et al.
Marine Drugs|April 16, 2015
Xyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunction in apolipoprotein e deficient miceLi-Yan Zhao, Jie Li, Feng Yuan, et al.
Marine Drugs|July 24, 2012
Marine cyclotripeptide X-13 promotes angiogenesis in zebrafish and human endothelial cells via PI3K/Akt/eNOS signaling pathwaysXi-Lin Lu, Zhong-Liang Xu, Xiao-Li Yao, et al.
Molecular Medicine Reports|July 25, 2020
Downregulation of miR‑193a‑3p via targeting cyclin D1 in thyroid cancerXiao-Jiao Li, Rong Wen, Dong-Yue Wen, et al.
Transplantation|April 21, 2018
Therapeutic Outcomes of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Multicenter StudyYonghua Li, Fengqi Duan, Haowen Xiao, et al.
Nature Communications|August 9, 2016
Synthetic viability by BRCA2 and PARP1/ARTD1 deficienciesXia Ding, Arnab Ray Chaudhuri, Elsa Callen, et al.
Pageof 41

Showing results (391-400 of 410) with videos related to

Sort By:
Pageof 41
Oncotarget|February 10, 2017
Pravastatin activates activator protein 2 alpha to augment the angiotensin II-induced abdominal aortic aneurysmsHui Ma, Wen-Jing Liang, Mei-Rong Shan, et al.
Gastrointestinal Endoscopy|December 13, 2021
Colorectal cancer patients advocating screening to their siblings: a randomized behavioral interventionLina Choe, Jerrald Lau, Si-Ying Fong, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 7, 2021
Clinical Implication of E2F Transcription Factor 1 in Hepatocellular Carcinoma TissuesWang-Yang Ye, Hui-Ping Lu, Jian-Di Li, et al.
Discover Oncology|July 4, 2025
Molecular mechanism and biological pathway of high-expressed RAD51 in regulating cell adhesion and potentially affecting oral squamous cell carcinomaYu-Xing Tang, Yu-Yan Pang, Yan Cui, et al.
Acta Pharmacologica Sinica|May 30, 2017
Xyloketal B alleviates cerebral infarction and neurologic deficits in a mouse stroke model by suppressing the ROS/TLR4/NF-κB inflammatory signaling pathwayNi Pan, Liu-Yi Lu, Mei Li, et al.
Marine Drugs|April 16, 2015
Xyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunction in apolipoprotein e deficient miceLi-Yan Zhao, Jie Li, Feng Yuan, et al.
Marine Drugs|July 24, 2012
Marine cyclotripeptide X-13 promotes angiogenesis in zebrafish and human endothelial cells via PI3K/Akt/eNOS signaling pathwaysXi-Lin Lu, Zhong-Liang Xu, Xiao-Li Yao, et al.
Molecular Medicine Reports|July 25, 2020
Downregulation of miR‑193a‑3p via targeting cyclin D1 in thyroid cancerXiao-Jiao Li, Rong Wen, Dong-Yue Wen, et al.
Transplantation|April 21, 2018
Therapeutic Outcomes of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Multicenter StudyYonghua Li, Fengqi Duan, Haowen Xiao, et al.
Nature Communications|August 9, 2016
Synthetic viability by BRCA2 and PARP1/ARTD1 deficienciesXia Ding, Arnab Ray Chaudhuri, Elsa Callen, et al.
Pageof 41